Phase 2 Apathy Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
SafetyPARKINSON DISEASE (Disorder)Apathy
Integrative Research Laboratories AB75 enrolled13 locationsNCT07461220
Recruiting
Phase 2
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+3 more
Sunnybrook Health Sciences Centre12 enrolled1 locationNCT07279740
Recruiting
Phase 1Phase 2
Accelerated rTMS vs. Sham for Stroke Apathy
StrokeMotivationApathy+4 more
Medical University of South Carolina40 enrolled1 locationNCT07113067
Completed
Phase 2
A randomised double blind, placebo-controlled study of Nefiracetam in patients with post- stroke apathy
Post stroke apathy
Fremantle Hospital and Health Service122 enrolled1 locationACTRN12609000975291